Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Tisotumab Vedotin
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Tisotumab vedotin Tivdak
®
(40 mg powder for concentrate for solution for infusion)
Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Links found
NICE TA1164: Tisotumab vedotin for treating recurrent or metastatic cervical cancer that has progressed on or after systemic treatment